Suchergebnisse - "McDonald, Kerrie L"

PubPharm (10)

1

Whole genome and biomarker analysis of patients with recurrent glioblastoma on bevacizumab : A subset analysis of the CABARET trial

enthalten in: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia | 2019

von Olafson, L. | Siddell, A. | Field, K. | +11

2

The challenges associated with molecular targeted therapies for glioblastoma

enthalten in: Journal of neuro-oncology | 2016

von Jue, T. | McDonald, K.

3

The challenges associated with molecular targeted therapies for glioblastoma

enthalten in: Journal of neuro-oncology | 2016

von Jue, T. | McDonald, K.

4

The challenges associated with molecular targeted therapies for glioblastoma

enthalten in: Journal of neuro-oncology | 2016

von Jue, T. | McDonald, K.

5

The challenges associated with molecular targeted therapies for glioblastoma

enthalten in: Journal of neuro-oncology | 2016

von Jue, T. | McDonald, K.

6

The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide

enthalten in: Neuro-oncology | 2015

von Rapkins, R. | Wang, F. | Nguyen, H. | +6

7

Incorporation of biomarkers in phase II studies of recurrent glioblastoma

enthalten in: Tumor biology | 2014

von Jue, T. | Hovey, E. | Davis, S. | +2

8

Incorporation of biomarkers in phase II studies of recurrent glioblastoma

enthalten in: Tumor biology | 2014

von Jue, T. | Hovey, E. | Davis, S. | +2

9

Incorporation of biomarkers in phase II studies of recurrent glioblastoma

enthalten in: Tumor biology | 2014

von Jue, T. | Hovey, E. | Davis, S. | +2

10

IQGAP1 and IGFBP2 : valuable biomarkers for determining prognosis in glioma patients

enthalten in: Journal of neuropathology and experimental neurology | 2007

von McDonald, K. | O'Sullivan, M. | Parkinson, J. | +12

1
[1]